GGrantIndex
← Leaderboards

Nathaniel W. Snyder

Thomas Jefferson University

$5,947,517
Attributed
$8,601,593
Total exposure
10
Grants
6
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $2.7M · FY201625
$5M$3.8M$2.5M$1.3M$0
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$8,601,593 · 10

By mechanism

R01$7,095,653 · 5
K22$485,190 · 1
R21$430,375 · 1
R03$313,000 · 2
R35$277,375 · 1

Top collaborators

Most similar at Thomas Jefferson University

Same institution · by research overlap

Others in their field

Top investigators on “Metabolism

Research focus

MetabolismMetabolicMediatingCellsResponseCarbonAcetyl Coenzyme ACell NucleusInsightMalignant NeoplasmsGlucoseHistone AcetylationEnzymesCytoplasmResolutionPathway InteractionsLipidsAtp Citrate (Pro-S)-LyaseFutureMetabolic PathwayAcyl Coenzyme ALiquid ChromatographyMolecularEpigenetic Process

Grant awards (27)

Metabolic compartmentalization and the regulation of histone propionylation in cancer$698,008
R01 · FY2025 · CA
Acylcarnitine Metabolism in Ovarian Cancer Chemoresistance$686,654
R01 · FY2025 · CA
Relevance of fatty acid handling in the adaptive response to mitochondrial dysfunction$525,673
R01 · FY2025 · DK
Metabolic and epigenetic reprogramming in cyclin E high ovarian cancer$308,991
R01 · FY2025 · CA
Measuring compartmentalized metabolism of cofactors$277,375
R35 · FY2025 · GM · contact PI
Metabolic and epigenetic reprogramming in cyclin E high ovarian cancer$212,508
R01 · FY2025 · CA
Relevance of fatty acid handling in the adaptive response to mitochondrial dysfunction$542,156
R01 · FY2024 · DK
Metabolic and epigenetic reprogramming in cyclin E high ovarian cancer$504,676
R01 · FY2024 · CA
Metabolic and epigenetic reprogramming in cyclin E high ovarian cancer$198,750
R01 · FY2024 · CA
Metabolic and epigenetic reprogramming in cyclin E high ovarian cancer$523,359
R01 · FY2023 · CA
Quantification of compartmentalized metabolism in eukaryotic systems$340,775
R01 · FY2023 · GM · contact PI
Metabolic and epigenetic reprogramming in cyclin E high ovarian cancer$533,073
R01 · FY2022 · CA
Quantification of compartmentalized metabolism in eukaryotic systems$340,775
R01 · FY2022 · GM · contact PI
Metabolic and epigenetic reprogramming in cyclin E high ovarian cancer$574,305
R01 · FY2021 · CA
Quantification of compartmentalized metabolism in eukaryotic systems$340,775
R01 · FY2021 · GM · contact PI
Liquid chromatography system replacement$89,901
R01 · FY2021 · GM · contact PI
Quantification of compartmentalized metabolism in eukaryotic systems$340,775
R01 · FY2020 · GM · contact PI
Quantification of compartmentalized metabolism in eukaryotic systems$286,224
R01 · FY2019 · GM · contact PI
Quantification of compartmentalized metabolism in eukaryotic systems$48,275
R01 · FY2019 · GM · contact PI
Prenatal biomarkers of exposure and individual susceptibility to endocrine disrupting compounds$161,730
K22 · FY2018 · ES · contact PI
Metabolism of propionic acid$78,250
R03 · FY2018 · HD · contact PI
Lipidomics of meconium in neurodevelopment$195,625
R21 · FY2017 · HD · contact PI
Prenatal biomarkers of exposure and individual susceptibility to endocrine disrupting compounds$161,730
K22 · FY2017 · ES · contact PI
Metabolism of propionic acid$78,250
R03 · FY2017 · HD · contact PI
Lipidomics of meconium in neurodevelopment$234,750
R21 · FY2016 · HD · contact PI
Prenatal biomarkers of exposure and individual susceptibility to endocrine disrupting compounds$161,730
K22 · FY2016 · ES · contact PI
The influence of prenatal maternal exposures on fetal sterol metabolomics$156,500
R03 · FY2016 · CA · contact PI